Depo-Medrol

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

buyitnow

download PIL (PIL)
29-05-2024
download SPC (SPC)
29-05-2024

active_ingredient:

Methylprednisolone acetate

PIL

                                DEPO-MEDROL
®
 
_methylprednisolone acetate_
CONSUMER MEDICINE INFORMATION
   
 
 
WHAT IS IN THIS LEAFLET
Please read this leaflet carefully
before being treated with DEPO-
MEDROL suspension for injection.
This leaflet answers some common
questions about DEPO-MEDROL. It
does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you being treated with
DEPO-MEDROL against the
benefits this medicine is expected to
have for you.
IF YOU HAVE ANY CONCERNS ABOUT THIS
MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
Consider keeping this leaflet even
after treatment with DEPO-
MEDROL is finished. You may need
to read it again.
WHAT DEPO-MEDROL
IS USED FOR
DEPO-MEDROL is used to treat
disorders of many organ systems
such as skin, lung, eye,
gastrointestinal tract, nervous system,
joints and blood. DEPO-MEDROL
works by reducing inflammation and
changing the body's natural ability to
respond when the immune response
is not working properly. It is also
used in certain conditions where the
adrenal gland doesn't function
correctly.
Your doctor may have prescribed
DEPO-MEDROL for another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY DEPO-
MEDROL HAS BEEN PRESCRIBED FOR
YOU.
This medicine is available only with
a doctor's prescription.
BEFORE TREATMENT WITH
DEPO-MEDROL
Some information is provided below.
However, always talk to your doctor
if you have concerns or questions
about your treatment.
_WHEN DEPO-MEDROL MUST_
_NOT BE USED_
DEPO-MEDROL MUST NOT BE
USED:
1. IF YOU HAVE AN ALLERGY TO:
•
methylprednisolone acetate
•
any of the other ingredients listed
under Product Description at the
end of this leaflet.
 Symptoms of an allergic reaction
may include skin rash, itching or
difficulty in breathing.
2. IF YOU HAVE A SEVERE FUNGAL
INFECTION
3. IT MUST NOT BE INJECTED INTO THE
SPINAL CORD (INTRATHECALLY OR
EPIDURAL) OR INTO A VEIN
(INTRAVENOUSLY)
4. IF YOU HAVE BEEN GIVEN A VA
                                
                                read_full_document
                                
                            

SPC

                                Version: pfpdepmi10713 
Supersedes: pfpdepmi10912 
 
Page 1 of 23 
PRODUCT INFORMATION 
DEPO-MEDROL
®
 
SUSPENSION FOR INJECTION
 
For Intramuscular, Intra-articular, Soft Tissue or Intralesional
Injection Only 
NOT FOR INTRAVENOUS, INTRATHECAL OR EPIDURAL USE 
NAME OF THE MEDICINE 
Australian Approved Name
(AAN):  methylprednisolone  acetate  which  is  the  6-methyl 
derivative of prednisolone.   
Chemical structure: 
 
Chemical name: 
11

,  17

,  21-trihydroxy-6

-methylpregna-1,4-diene-3,20-dione 
acetate 
Molecular Formula 
 C
24
H
32
O
6
 
Molecular weight: 
 416.51 
CAS registry number: 
 53-36-1 
DESCRIPTION 
Methylprednisolone acetate is a white or practically white,
odourless, crystalline powder 
which melts at about 215
o
C with some decomposition.  It is soluble in dioxane, sparingly 
soluble in acetone, in alcohol, in chloroform, and in methanol, and
slightly soluble in ether.  It 
is practically insoluble in water. 
DEPO-MEDROL  is  an  anti-inflammatory  glucocorticoid,  for  intramuscular,  intra-articular, 
soft tissue or intralesional injection. 
It is available in a 40 mg/mL vial. 
Version: pfpdepmi10713 
Supersedes: pfpdepmi10912 
 
Page 2 of 23 
Each mL contains: 
Methylprednisolone acetate 
40 mg 
Macrogol 3350 
29 mg 
Sodium chloride 
8.7 mg 
Miripirium chloride  
added as preservative. 
0.195 mg 
 
 
 
 
When necessary, pH is adjusted with sodium hydroxide and/or hydrochloric acid.  The pH of 
the finished product remains within the USP specified range,
i.e. 3.0 to 7.0. 
PHARMACOLOGY 
Naturally  occurring  glucocorticoids  (hydrocortisone),  which  also  have  salt-retaining 
properties, are used in replacement therapy in adrenocortical deficiency states.  Their
synthetic 
analogues  are  used  primarily  for  their  potent  anti-inflammatory  effects  in  disorders  of  many 
or
                                
                                read_full_document
                                
                            

view_documents_history